Yamaha Outdoor Access Initiative Awards Over $170,000 in Second Quarter Grants to Rebuild OHV Trails Affected by Natural Disasters
September 19, 2024 15:00 ET
|
Yamaha Motor Corp., USA
MARIETTA, Ga., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, awarded more than $170,000 in grants through its Yamaha Outdoor Access Initiative (OAI) in the second quarter of 2024,...
Inter&Co Inc. Reports Record Profit in Q2, Advances 60/30/30 Plan
August 07, 2024 07:19 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the leading financial super app providing financial and digital commerce services to over 33...
CAI and United Way Launch the CAI United Fund to Support Student Success
July 23, 2024 09:01 ET
|
CAI
CAI, a global services firm, announced today a new partnership with United Way of the Greater Lehigh Valley, to form the CAI United Fund.
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
June 12, 2024 16:01 ET
|
Barinthus Biotherapeutics
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
Azuria Announces Acquisition of Infrastructure Services Group LLC and Subsidiaries
June 11, 2024 10:36 ET
|
Azuria Water Solutions
Azuria Announces Acquisition of Infrastructure Services Group LLC and Subsidiaries
Brandon Capital Announces Sixth Fund with A$270 million (US$180 million) Initial Close to Drive Life Science Innovation
June 03, 2024 19:00 ET
|
Brandon Capital
FOR IMMEDIATE RELEASE - 9:00 AM AEST MELBOURNE 4 JUNE 2024 AND 19.00 PM EDT NEW YORK 3 JUNE MELBOURNE, Australia, June 04, 2024 (GLOBE NEWSWIRE) -- Brandon Capital, Australasia’s leading life...
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
June 03, 2024 08:14 ET
|
AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...
Moody's assigns debut AA+.br ratings to Inter, recognizing strong financial position
May 31, 2024 10:16 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, May 31, 2024 (GLOBE NEWSWIRE) -- Inter&Co (NASDAQ: INTR), the leading financial super app serving over 32 million customers across the Americas, is pleased to announce...
Inter&Co doubles down on SMEs through acquisition of Granito
May 28, 2024 07:33 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, May 28, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), announces that Banco Inter S.A. entered into a share purchase agreement to acquire the...
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024 17:00 ET
|
Mural Oncology, Inc.
ARTISTRY-3 trial is being conducted to evaluate less frequent dosing of nemvaleukin alfa, Mural’s late-stage lead candidate Nemvaleukin demonstrated pharmacodynamic proof of mechanism in ARTISTRY-3...